Abstract: The present disclosure relates to antibodies that specifically bind soluble and membrane forms of human TNFa, compositions comprising such TNFa antibodies, and methods of using such TNFa antibodies and compositions.
| # | Name | Date |
|---|---|---|
| 1 | 202417039992-STATEMENT OF UNDERTAKING (FORM 3) [22-05-2024(online)].pdf | 2024-05-22 |
| 3 | 202417039992-Sequence Listing in PDF [22-05-2024(online)].pdf | 2024-05-22 |
| 4 | 202417039992-REQUEST FOR EXAMINATION (FORM-18) [22-05-2024(online)].pdf | 2024-05-22 |
| 5 | 202417039992-PROOF OF RIGHT [22-05-2024(online)].pdf | 2024-05-22 |
| 6 | 202417039992-PRIORITY DOCUMENTS [22-05-2024(online)].pdf | 2024-05-22 |
| 7 | 202417039992-POWER OF AUTHORITY [22-05-2024(online)].pdf | 2024-05-22 |
| 8 | 202417039992-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [22-05-2024(online)].pdf | 2024-05-22 |
| 9 | 202417039992-FORM 18 [22-05-2024(online)].pdf | 2024-05-22 |
| 10 | 202417039992-FORM 1 [22-05-2024(online)].pdf | 2024-05-22 |
| 11 | 202417039992-DRAWINGS [22-05-2024(online)].pdf | 2024-05-22 |
| 12 | 202417039992-DECLARATION OF INVENTORSHIP (FORM 5) [22-05-2024(online)].pdf | 2024-05-22 |
| 13 | 202417039992-COMPLETE SPECIFICATION [22-05-2024(online)].pdf | 2024-05-22 |
| 14 | 202417039992-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [22-05-2024(online)].pdf | 2024-05-22 |
| 15 | 202417039992-FORM 3 [27-09-2024(online)].pdf | 2024-09-27 |